Notes to the Financial Statements
 
The Year in Brief
  Letter to the Shareholders
  Shares and Shareholders
  Board of Directors' Report
  Consolidated Income Statement
  Pro forma Income Statement
  Consolidated Balance Sheet
  Consolidated Cash Flow Statement
  Income Statement of Parent Company
  Balance Sheet of Parent Company
  Cash Flow Statement of Parent Company
  Accounting Principles
Notes to the Financial Statements
  Proposal for Profit Distribution
  Auditors' Report
  Financial Indicators 1997-2001
  Calculation of Financial Ratios
  Quarterly Development
  Download Centre
   
 

This web annual report has been abridged and modified for ease of use. The complete annual report will be released during week 13, after which you can also download the printable PDF version.

NOTES TO THE PARENT COMPANY FINANCIAL STATEMENTS
 
Displaying Notes 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 out of total 41 notes  
(Figures are in EUR thousands unless otherwise stated) 2001 2000
NOTES TO THE PARENT COMPANY BALANCE SHEET
 
30. FIXED ASSETS
  Intangible assets Tangible assets
  Intangible rights Goodwill Other capitalised expen-
diture
Land areas Buildings Machinery and equipment Other
tangible
assets
Acquisition value 1 Jan 8,242 39,595 1,661 929 62,802 27,347 240
Increase 291   80   243 1,637 -
Decrease - - - - - -76 -
Other changes - - - - -2,113 2,066 -
Acquisition value 31 Dec 8,533 39,595 1,741 929 60,932 30,974 240
               
Accumulated depr. 1 Jan -6,078 -25,135 -1,657   -18,353 -22,673  
Increase -581 -10,556 -4 - -1,713 -2,820 -
Decrease - - - - - 60 -
Accumulated depr. 31 Dec -6,659 -35,691 -1,661 0 -20,066 -25,433 0
               
Value adjustments
1 Jan & 31 Dec
      420 2,355    
               
Bookvalue 31 Dec 2001 1,874 3,904 80 1,348 43,221 5,541 240
               
Bookvalue 31 Dec 2000 2,164 14,460 4 1,348 46,804 4,674 240
 
31. GROUP COMPANIES
 
Company Registered office Group share of Parent
company
share of
holding %

Shares owned by
the parent company

holding
and votes %
share-
holders'
equity
Number
of shares
Nominal
value
Book
value
Nomeco A/S Copenhagen, Denmark 100 82,019 100 7,200,000 19,364 197,155
Tamro AB Gothenburg, Sweden 100 85,950 - - - -
Tamro Health Care AB Gothenburg, Sweden 100 14 - - - -
Tamro Sweden AB Stockholm, Sweden 100 15,174 100 1,000 11 34,418
Tamro SIA Riga, Latvia 100 4,369 100 215 2,358 1,376
Hansa Pharma Balticum SIA Riga, Latvia 100 1,159 - - - -
Hansa Pharma SIA Riga, Latvia 100 2,135 - - - -
Tamro MedLab AB Gothenburg, Sweden 100 1,172 - - - -
Kemistien Oy Vantaa, Finland 100 1,750 100 1,000,000 1,682 3,560
Tamro UAB Kaunas, Lithuania 100 5,269 100 51,809 7,352 5,920
Apokjeden AS Skårer, Norway 49 16,912 49 80,330 1,010 47,116
Tamro Eesti AS Tallinn, Estonia 100 3,062 100 5,500 352 530
Medinord OÜ Tallinn, Estonia 100 0 - - - -
Koduapteek OÜ Tallinn, Estonia 100 0 - - - -
Tamro MedLab A/S Roskilde, Denmark 100 486 - - - -
Tamro MedLab AS Skårer, Norway 100 429 - - - -
Tamro MedLab Oy Vantaa, Finland 100 2,304 100 5,000 5,000 5,000
Medinord Oy Vantaa, Finland 100 435 100 12 163 895
Tam-Drug Oy Vantaa, Finland 100 31 100 2,000 49 49
Tamro Russia Oy Vantaa, Finland 100 153 100 96,318 100 170
Pharm Tamda 77 S:t Petersburg, Russia 85 -2 85 2,805 20 0
              296,189
               
Other subsidiaries, incl. non-operational       1,435
              297,625
 
32. OTHER SHARES AND PARTICIPATIONS
 
  Shares owned by
the parent company
  Number of shares Nominal value
Finnish Central Securities Depository Ltd. 8 27
Helsinki Stock Exchange Ltd 24,400 27
Telephone company shares etc.   8
Housing corporations   114
Real estate and other shares   233
    409
Own shares acquired by the company 341,000 975
     
Own shares are valued at the acquisition cost. The share price at year-end was EUR 3.59.
 
(Figures are in EUR thousands unless otherwise stated) 2001 2000
 
33. RECEIVABLES AND LIABILITIES
     
Intra-group items    
     
Financial assets    
  Loan receivables 122,960 127,949
     
Long-term receivables    
  Loan receivables 72,691 72,141
     
Short-term receivables from Group companies    
  Accounts receivable 10,485 2,660
  Prepaid expenses and accrued income 18,642 9,203
  Loan receivables 46,125 48,259
  75,252 60,122
Liabilities to Group companies    
  Accounts payable 134 1,747
  Accrued liabilities 235 81
  Other short-term liabilities 67,398 46,360
  67,767 48,188
 
34. PREPAID EXPENSES AND ACCRUED INCOME
     
Sale of shares 73,109 -
Income tax receivable - 12,981
Financial income 2,068 2,584
Prepaid expenses 417 2,074
Other income 2,240 1,890
Total 77,834 19,529
 
35. CHANGES IN SHAREHOLDERS' EQUITY
               
  Share capital Share premium account Revaluation
reserve
Fund for own shares Other reserves Retained earnings Total equity
Equity
31 Dec 1999
120,365 143 1,093 13,608 0 377,402 512,612
Subscription of new shares 1 1         2
Decrease -5,529 5,495       34 0
Cancelled own shares       -17,372     -17,372
Dividend           -17,174 -17,174
Net profit for the year           -8,655 -8,655
Fund for own shares       4,739   -4,739 0
Write-down of own shares       -406     -406
Donations           -1 -1
Equity
31 Dec 2000
114,837 5,640 1,093 569 0 346,867 469,006
               
Subscription of new shares             0
Decrease             0
Cancelled own shares             0
Dividend           -5,725 -5,725
Net profit for the year           49,806 49,806
Fund for own shares             0
Write-down of own shares       406     406
Donations             0
Other change           1 1
Equity
31 Dec 2001
114,837 5,640 1,093 975 0 390,949 513,494
     
(Figures are in EUR thousands unless otherwise stated) 2001 2000
 
36. ACCUMULATED DEPRECIATION DIFFERENCE
     
Accelerated depreciation    
  Intangible rights 422 402
  Goodwill 3,904 14,460
  Other capitalised expenditure 4 2
  Buildings 29,024 29,838
  Machinery and equipment -430 335
  32,924 45,037
 
37. OBLIGATORY RESERVES
     
Reserve for taxes 2,588 2,758
Other obligatory reserves 292 -
  2,880 2,758
 
38. LONG-TERM LIABILITIES
     
Long-term liabilities fall due as follows:    
  2003 5,424 -
  2004-2006 8,136 -
  13,560 -
     
Foreign currency breakdown of long-term liabilities:    
  EUR 13,560 -
 
39. ACCRUED EXPENSES AND DEFERRED INCOME
     
Personnel expenses 2,172 1,806
Financial expenses 742 803
IT expenses 99 160
Income tax liability 3,933 116
Other accrued expenses and deferred income 777 1,947
Total 7,723 4,832
 
OTHER NOTES
 
40. CONTINGENT LIALIBILITIES
     
Mortgages (1)    
 For own debts 23,010 2,943
     
Guarantees    
  For subsidiaries 35,714 26,840
  For debts of others 11,008 38
  46,722 26,878
Other commitments    
  Leasing commitments    
    Next year 1,177 1,807
    Over one year 536 1,148
  Rent commitments 497 1,095
  Repurchase commitments 28 37
  Other commitments - 74
  2,238 4,161
     
(1) Parent company's liabilities, secured by mortgages 18,984 23,583
 
41. DERIVATIVE FINANCIAL INSTRUMENTS
     
Derivatives - notional amounts    
Currency instruments    
  Currency forward contracts 144,436 99,739
  Currency options - purchased - 21,494
  Currency options - sold - 21,494
Interest rate instruments    
  Interest rate forward contracts and futures - 0
  Interest rate option contracts - 53,598
  Interest rate swaps 10,000 -
     
Derivatives - market value    
Currency instruments    
  Currency forward contracts 643 818
  Currency options 0 0
Interest rate instruments    
  Interest rate forward contracts and futures - 0
  Interest rate option contracts - -1
  Interest rate swaps 29 -
     
The notional amounts of derivatives summarised here do not represent amounts actually exchanged between the parties and are thus not a measure of the parent company's derivatives-related exposure. According to the Finance Policy derivatives are used only to hedge the underlying business.  
 
Displaying Notes 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 out of total 41 notes  
 
PDF document
 
   
 
Tamro Web Annual Report 2001,
Copyright © Tamro Corporation, All rights reserved